Timber Creek Capital Management LLC Novartis Ag Transaction History

Timber Creek Capital Management LLC

  • $335 Million
  • Q3 2024

A detailed history of Timber Creek Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Timber Creek Capital Management LLC holds 42,368 shares of NVS stock, worth $4.42 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
42,368
Previous 50,971 16.88%
Holding current value
$4.42 Million
Previous $5.43 Million 10.19%
% of portfolio
1.46%
Previous 1.7%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $913,036 - $1.04 Million
-8,603 Reduced 16.88%
42,368 $4.87 Million
Q2 2024

Jul 18, 2024
BUY
$92.57 - $107.37 $241,329 - $279,913
2,607 Added 5.39%
50,971 $5.43 Million
Q1 2024

Apr 03, 2024
SELL
$95.27 - $108.47 $344,686 - $392,444
-3,618 Reduced 6.96%
48,364 $4.68 Million
Q4 2023

Jan 11, 2024
BUY
$92.27 - $101.54 $24,636 - $27,111
267 Added 0.52%
51,982 $5.25 Million
Q3 2023

Oct 18, 2023
SELL
$94.73 - $105.13 $1.29 Million - $1.44 Million
-13,657 Reduced 20.89%
51,715 $5.27 Million
Q2 2023

Jul 20, 2023
SELL
$92.52 - $104.91 $14,895 - $16,890
-161 Reduced 0.25%
65,372 $6.6 Million
Q1 2023

Apr 06, 2023
SELL
$80.03 - $92.81 $210,558 - $244,183
-2,631 Reduced 3.86%
65,533 $6.03 Million
Q4 2022

Jan 23, 2023
SELL
$75.55 - $92.52 $41,250 - $50,515
-546 Reduced 0.79%
68,164 $0
Q3 2022

Oct 12, 2022
SELL
$74.61 - $87.26 $63,866 - $74,694
-856 Reduced 1.23%
68,710 $5.22 Million
Q2 2022

Jul 13, 2022
SELL
$80.52 - $93.75 $32,046 - $37,312
-398 Reduced 0.57%
69,566 $5.88 Million
Q1 2022

Apr 26, 2022
BUY
$80.11 - $90.62 $7,610 - $8,608
95 Added 0.14%
69,964 $6.14 Million
Q4 2021

Jan 31, 2022
BUY
$79.7 - $88.13 $107,595 - $118,975
1,350 Added 1.97%
69,869 $6.11 Million
Q3 2021

Oct 08, 2021
BUY
$81.78 - $95.14 $272,899 - $317,482
3,337 Added 5.12%
68,519 $5.6 Million
Q2 2021

Jul 29, 2021
BUY
$85.24 - $94.15 $811,655 - $896,496
9,522 Added 17.11%
65,182 $5.95 Million
Q1 2021

Apr 19, 2021
BUY
$83.5 - $98.47 $1.95 Million - $2.3 Million
23,316 Added 72.09%
55,660 $4.76 Million
Q4 2020

Jan 25, 2021
BUY
$78.07 - $94.43 $15,613 - $18,886
200 Added 0.62%
32,344 $3.05 Million
Q3 2020

Oct 20, 2020
SELL
$82.14 - $91.0 $508,857 - $563,745
-6,195 Reduced 16.16%
32,144 $2.8 Million
Q2 2020

Jul 31, 2020
BUY
$80.93 - $91.1 $45,320 - $51,016
560 Added 1.48%
38,339 $3.35 Million
Q1 2020

Apr 17, 2020
SELL
$70.67 - $99.01 $2,756 - $3,861
-39 Reduced 0.1%
37,779 $3.11 Million
Q4 2019

Jan 30, 2020
BUY
$84.35 - $95.37 $8,856 - $10,013
105 Added 0.28%
37,818 $3.58 Million
Q3 2019

Oct 31, 2019
SELL
$85.54 - $94.26 $191,609 - $211,142
-2,240 Reduced 5.61%
37,713 $3.28 Million
Q2 2019

Aug 05, 2019
BUY
$75.4 - $92.8 $160,979 - $198,128
2,135 Added 5.65%
39,953 $3.65 Million
Q1 2019

Apr 23, 2019
BUY
$75.32 - $86.15 $7,531 - $8,615
100 Added 0.27%
37,818 $3.64 Million
Q4 2018

Jan 30, 2019
SELL
$73.66 - $82.02 $13,627 - $15,173
-185 Reduced 0.49%
37,718 $3.24 Million
Q3 2018

Oct 26, 2018
BUY
$66.94 - $77.43 $7,363 - $8,517
110 Added 0.29%
37,903 $3.27 Million
Q2 2018

Aug 07, 2018
BUY
$64.91 - $73.36 $178,827 - $202,106
2,755 Added 7.86%
37,793 $2.85 Million
Q1 2018

Apr 30, 2018
SELL
$70.39 - $84.15 $21,820 - $26,086
-310 Reduced 0.88%
35,038 $2.83 Million
Q4 2017

Jan 31, 2018
BUY
$72.33 - $77.64 $28,932 - $31,056
400 Added 1.14%
35,348 $2.97 Million
Q3 2017

Nov 07, 2017
BUY
$74.14 - $77.27 $6,301 - $6,567
85 Added 0.24%
34,948 $3 Million
Q2 2017

Aug 14, 2017
BUY
N/A
80 Added 0.23%
34,863 $2.91 Million
Q2 2017

Aug 11, 2017
BUY
N/A
34,783
34,783 $2.58 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Timber Creek Capital Management LLC Portfolio

Follow Timber Creek Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Timber Creek Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Timber Creek Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email